@CharlesTe@drjohnm I’ve wondered this, but there seems to be a high percentage of people who discontinue dabigatran d/t GI side effects. And the GI bleed risk seems to be higher.
What do you tell patients? The cost is obviously a huge advantage.
@ahmederaky@SUO_YUO I built something similar, but always had trouble figuring out how to migrate data when a user gets a new phone.
How did you end up accomplishing this?
Nice job!
Can standard ECGs flag aortic stenosis years earlier and predict higher mortality post-TAVR? Yes. 🫀
@CardioCareToday highlighted groundbreaking research by Dr. @MattSegar (@Texas_Heart). At AccurKardia, our investigational AK-AVS pipeline is turning the standard ECG into a powerful, predictive biomarker for structural heart disease.
Check the interview: https://t.co/c8jir8Iwsv
#AorticStenosis #TAVR #HealthTech #Cardiology #MedTech #AI #BetterOutcomes
New peer-reviewed evidence for AI-ECG in aortic stenosis. Big thanks to Dr. @MattSegar and the Texas Heart Institute team for leading this work.
https://t.co/9X1w5x1epf
AK-AVS is investigational and not FDA-cleared.
Development and Validation of a Novel Machine Learning-Based Algorithm to Predict Incident Atrial Fibrillation – A Multicohort Analysis
https://t.co/BZq4eREego
POLY-HF trial: Polypill containing metoprolol, spironolactone, and empagliflozin improved EF, QoL, and adherence, and reduced HF hospitalizations at 6 months in HFrEF patients compared to usual care. #AHA25 View the slides here: https://t.co/98PJIQpLRQ